MJ Biopharma
Navi Mumbai, India· Est.
Indian‑based pharma biotech firm delivering APIs and specialty products with a focus on diabetes therapeutics and global market reach.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Indian‑based pharma biotech firm delivering APIs and specialty products with a focus on diabetes therapeutics and global market reach.
DiabetesGeneral Medicine
Technology Platform
Conventional API manufacturing combined with biotechnological research platforms at the MJ Institute of Research, adhering to GMP and international quality certifications.
Opportunities
Leverage existing GMP certifications to expand API exports to emerging markets and develop diabetes-focused generics and nutraceuticals.
Risk Factors
Regulatory changes, price pressure in generic markets, and competition from larger multinational API manufacturers.
Competitive Landscape
Faces competition from Indian API leaders such as Sun Pharma, Cipla, and Lupin, but differentiates through its diversified conglomerate structure and strong export accreditation.